Biohaven (BHVN) Cash & Current Investments (2021 - 2026)

Biohaven has disclosed Cash & Current Investments across 6 years of filings, most recently posting $347.8 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $347.8 million, up 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $347.8 million (up 7.77% YoY), and the FY2025 annual result was $319.1 million, down 34.33% from the prior year.
• Cash & Current Investments came in at $347.8 million for Q1 2026 at Biohaven, up from $319.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $486.0 million in Q4 2024 to a low of $23.2 million in Q2 2022.
• The 5-year median for Cash & Current Investments is $322.7 million (2025), against an average of $295.2 million.
• Across the five-year window, Cash & Current Investments sank 85.99% in 2022 and jumped 863.86% in 2023, its largest moves.
• Biohaven's Cash & Current Investments stood at $465.3 million in 2022, then slipped by 17.95% to $381.8 million in 2023, then advanced by 27.28% to $486.0 million in 2024, then plunged by 34.33% to $319.1 million in 2025, then rose by 8.99% to $347.8 million in 2026.
• The last three Cash & Current Investments figures came in at $347.8 million (Q1 2026), $319.1 million (Q4 2025), and $260.2 million (Q3 2025), per Business Quant data.